Cargando…

The clinical and prognostic value of late Gadolinium enhancement imaging in heart failure with mid-range and preserved ejection fraction

Heart failure (HF) with mid-range or preserved ejection fraction (HFmrEF; HFpEF) is a heterogeneous disorder that could benefit from strategies to identify subpopulations at increased risk. We tested the hypothesis that HFmrEF and HFpEF patients with myocardial scars detected with late gadolinium en...

Descripción completa

Detalles Bibliográficos
Autores principales: van Woerden, Gijs, van Veldhuisen, Dirk J., Gorter, Thomas M., Willems, Tineke P., van Empel, Vanessa P. M., Peters, Aniek, Pundziute, Gabija, op den Akker, Jeroen W., Rienstra, Michiel, Westenbrink, B. Daan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794962/
https://www.ncbi.nlm.nih.gov/pubmed/34292389
http://dx.doi.org/10.1007/s00380-021-01910-2
_version_ 1784640942137933824
author van Woerden, Gijs
van Veldhuisen, Dirk J.
Gorter, Thomas M.
Willems, Tineke P.
van Empel, Vanessa P. M.
Peters, Aniek
Pundziute, Gabija
op den Akker, Jeroen W.
Rienstra, Michiel
Westenbrink, B. Daan
author_facet van Woerden, Gijs
van Veldhuisen, Dirk J.
Gorter, Thomas M.
Willems, Tineke P.
van Empel, Vanessa P. M.
Peters, Aniek
Pundziute, Gabija
op den Akker, Jeroen W.
Rienstra, Michiel
Westenbrink, B. Daan
author_sort van Woerden, Gijs
collection PubMed
description Heart failure (HF) with mid-range or preserved ejection fraction (HFmrEF; HFpEF) is a heterogeneous disorder that could benefit from strategies to identify subpopulations at increased risk. We tested the hypothesis that HFmrEF and HFpEF patients with myocardial scars detected with late gadolinium enhancement (LGE) are at increased risk for all-cause mortality. Symptomatic HF patients with left ventricular ejection fraction (LVEF) > 40%, who underwent cardiac magnetic resonance (CMR) imaging were included. The presence of myocardial LGE lesions was visually assessed. T1 mapping was performed to calculate extracellular volume (ECV). Multivariable logistic regression analyses were used to determine associations between clinical characteristics and LGE. Cox regression analyses were used to assess the association between LGE and all-cause mortality. A total of 110 consecutive patients were included (mean age 71 ± 10 years, 49% women, median N-terminal brain natriuretic peptide (NT-proBNP) 1259 pg/ml). LGE lesions were detected in 37 (34%) patients. Previous myocardial infarction and increased LV mass index were strong and independent predictors for the presence of LGE (odds ratio 6.32, 95% confidence interval (CI) 2.07–19.31, p = 0.001 and 1.68 (1.03–2.73), p = 0.04, respectively). ECV was increased in patients with LGE lesions compared to those without (28.6 vs. 26.6%, p = 0.04). The presence of LGE lesions was associated with a fivefold increase in the incidence of all-cause mortality (hazards ratio 5.3, CI 1.5–18.1, p = 0.009), independent of age, sex, New York Heart Association (NYHA) functional class, NT-proBNP, LGE mass and LVEF. Myocardial scarring on CMR is associated with increased mortality in HF patients with LVEF > 40% and may aid in selecting a subpopulation at increased risk. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00380-021-01910-2.
format Online
Article
Text
id pubmed-8794962
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Japan
record_format MEDLINE/PubMed
spelling pubmed-87949622022-02-02 The clinical and prognostic value of late Gadolinium enhancement imaging in heart failure with mid-range and preserved ejection fraction van Woerden, Gijs van Veldhuisen, Dirk J. Gorter, Thomas M. Willems, Tineke P. van Empel, Vanessa P. M. Peters, Aniek Pundziute, Gabija op den Akker, Jeroen W. Rienstra, Michiel Westenbrink, B. Daan Heart Vessels Original Article Heart failure (HF) with mid-range or preserved ejection fraction (HFmrEF; HFpEF) is a heterogeneous disorder that could benefit from strategies to identify subpopulations at increased risk. We tested the hypothesis that HFmrEF and HFpEF patients with myocardial scars detected with late gadolinium enhancement (LGE) are at increased risk for all-cause mortality. Symptomatic HF patients with left ventricular ejection fraction (LVEF) > 40%, who underwent cardiac magnetic resonance (CMR) imaging were included. The presence of myocardial LGE lesions was visually assessed. T1 mapping was performed to calculate extracellular volume (ECV). Multivariable logistic regression analyses were used to determine associations between clinical characteristics and LGE. Cox regression analyses were used to assess the association between LGE and all-cause mortality. A total of 110 consecutive patients were included (mean age 71 ± 10 years, 49% women, median N-terminal brain natriuretic peptide (NT-proBNP) 1259 pg/ml). LGE lesions were detected in 37 (34%) patients. Previous myocardial infarction and increased LV mass index were strong and independent predictors for the presence of LGE (odds ratio 6.32, 95% confidence interval (CI) 2.07–19.31, p = 0.001 and 1.68 (1.03–2.73), p = 0.04, respectively). ECV was increased in patients with LGE lesions compared to those without (28.6 vs. 26.6%, p = 0.04). The presence of LGE lesions was associated with a fivefold increase in the incidence of all-cause mortality (hazards ratio 5.3, CI 1.5–18.1, p = 0.009), independent of age, sex, New York Heart Association (NYHA) functional class, NT-proBNP, LGE mass and LVEF. Myocardial scarring on CMR is associated with increased mortality in HF patients with LVEF > 40% and may aid in selecting a subpopulation at increased risk. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00380-021-01910-2. Springer Japan 2021-07-22 2022 /pmc/articles/PMC8794962/ /pubmed/34292389 http://dx.doi.org/10.1007/s00380-021-01910-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
van Woerden, Gijs
van Veldhuisen, Dirk J.
Gorter, Thomas M.
Willems, Tineke P.
van Empel, Vanessa P. M.
Peters, Aniek
Pundziute, Gabija
op den Akker, Jeroen W.
Rienstra, Michiel
Westenbrink, B. Daan
The clinical and prognostic value of late Gadolinium enhancement imaging in heart failure with mid-range and preserved ejection fraction
title The clinical and prognostic value of late Gadolinium enhancement imaging in heart failure with mid-range and preserved ejection fraction
title_full The clinical and prognostic value of late Gadolinium enhancement imaging in heart failure with mid-range and preserved ejection fraction
title_fullStr The clinical and prognostic value of late Gadolinium enhancement imaging in heart failure with mid-range and preserved ejection fraction
title_full_unstemmed The clinical and prognostic value of late Gadolinium enhancement imaging in heart failure with mid-range and preserved ejection fraction
title_short The clinical and prognostic value of late Gadolinium enhancement imaging in heart failure with mid-range and preserved ejection fraction
title_sort clinical and prognostic value of late gadolinium enhancement imaging in heart failure with mid-range and preserved ejection fraction
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794962/
https://www.ncbi.nlm.nih.gov/pubmed/34292389
http://dx.doi.org/10.1007/s00380-021-01910-2
work_keys_str_mv AT vanwoerdengijs theclinicalandprognosticvalueoflategadoliniumenhancementimaginginheartfailurewithmidrangeandpreservedejectionfraction
AT vanveldhuisendirkj theclinicalandprognosticvalueoflategadoliniumenhancementimaginginheartfailurewithmidrangeandpreservedejectionfraction
AT gorterthomasm theclinicalandprognosticvalueoflategadoliniumenhancementimaginginheartfailurewithmidrangeandpreservedejectionfraction
AT willemstinekep theclinicalandprognosticvalueoflategadoliniumenhancementimaginginheartfailurewithmidrangeandpreservedejectionfraction
AT vanempelvanessapm theclinicalandprognosticvalueoflategadoliniumenhancementimaginginheartfailurewithmidrangeandpreservedejectionfraction
AT petersaniek theclinicalandprognosticvalueoflategadoliniumenhancementimaginginheartfailurewithmidrangeandpreservedejectionfraction
AT pundziutegabija theclinicalandprognosticvalueoflategadoliniumenhancementimaginginheartfailurewithmidrangeandpreservedejectionfraction
AT opdenakkerjeroenw theclinicalandprognosticvalueoflategadoliniumenhancementimaginginheartfailurewithmidrangeandpreservedejectionfraction
AT rienstramichiel theclinicalandprognosticvalueoflategadoliniumenhancementimaginginheartfailurewithmidrangeandpreservedejectionfraction
AT westenbrinkbdaan theclinicalandprognosticvalueoflategadoliniumenhancementimaginginheartfailurewithmidrangeandpreservedejectionfraction
AT vanwoerdengijs clinicalandprognosticvalueoflategadoliniumenhancementimaginginheartfailurewithmidrangeandpreservedejectionfraction
AT vanveldhuisendirkj clinicalandprognosticvalueoflategadoliniumenhancementimaginginheartfailurewithmidrangeandpreservedejectionfraction
AT gorterthomasm clinicalandprognosticvalueoflategadoliniumenhancementimaginginheartfailurewithmidrangeandpreservedejectionfraction
AT willemstinekep clinicalandprognosticvalueoflategadoliniumenhancementimaginginheartfailurewithmidrangeandpreservedejectionfraction
AT vanempelvanessapm clinicalandprognosticvalueoflategadoliniumenhancementimaginginheartfailurewithmidrangeandpreservedejectionfraction
AT petersaniek clinicalandprognosticvalueoflategadoliniumenhancementimaginginheartfailurewithmidrangeandpreservedejectionfraction
AT pundziutegabija clinicalandprognosticvalueoflategadoliniumenhancementimaginginheartfailurewithmidrangeandpreservedejectionfraction
AT opdenakkerjeroenw clinicalandprognosticvalueoflategadoliniumenhancementimaginginheartfailurewithmidrangeandpreservedejectionfraction
AT rienstramichiel clinicalandprognosticvalueoflategadoliniumenhancementimaginginheartfailurewithmidrangeandpreservedejectionfraction
AT westenbrinkbdaan clinicalandprognosticvalueoflategadoliniumenhancementimaginginheartfailurewithmidrangeandpreservedejectionfraction